Our data are therefore consistent with a model whereby LMO2 is under the control of homeobox genes such as HOXA5 acting through the +1 enhancer to mediate ectopic expression in a subset of T-ALL patients with immature phenotype. Here, HOXA5 is linked to acute lymphoblastic leukemia.